Page 1

compugen FROM CODE TO CURE® CCGCCTGATCCGAC TCTCTCCGCCTGATA AGCCGCTTCTC TCTCCGCCTGATCCGACCAGC ATCCGAC CTGATCCGACCAGCCGCTTCTC CCAGCCGCTTCTC Corporate Overview For investors and analysts CGCTTCTC CGACCAGCCGCTTCTCTCCGCCTG CTTCTCTCCCCCTGATCCGACCAGCC TCTCCGCCTGATCCGACCAGCCGCTTCTCTCCGCCT August 2026